Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 12:54 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 399 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Psychiatry Clear all

Conditions: Systemic Lupus Erythematosus (Sle), Primary Ovarian Insufficiency (Poi)
Interventions: Not listed
Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIH
Eligibility: 18 Years to 120 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Psychiatric Disorder
Interventions: Pharmacogentic Analysis; Genetic
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Refractory Epilepsy
Interventions: Electrical Stimulation; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Suicide, Psychiatric Hospitalization
Interventions: LifePlans; Behavioral
Lead sponsor: Butler Hospital; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Depression
Interventions: Not listed
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Mental Health Issue, COVID-19
Interventions: Music; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 16 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: New Haven, Connecticut

Conditions: Schizophrenia, Psychiatric Disorders
Interventions: OPC-34712; Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Miami, Florida • Minneapolis, Minnesota

Conditions: Study Focusing on Integrated Versus Non-integrated Psychiatric Care in, Opioid-dependent and Methadone Treated Patients With Other Psychiatric, Diagnoses
Interventions: Counseling compliance; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 380 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Chromosome 22q11.2 Deletion Syndrome
Interventions: Not listed
Lead sponsor: UMC Utrecht; Other
Eligibility: 8 Years to 20 Years
Enrollment: 175 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2012
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Mental Health Issue, Substance Use Disorders
Interventions: Co-Active Therapeutic Theatre (Co-ATT); Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Adolescent Substance Use
Interventions: Family Check-up, Parent psychoeducation; Behavioral
Lead sponsor: Brown University; Other
Eligibility: 12 Years to 16 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Schizophenia Disorder, Schizoaffective Disorder, Bipolar Disorder, Psychiatric Disorders
Interventions: Reduction of anticholinergic medication; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 4
States / cities: Altoona, Pennsylvania • Erie, Pennsylvania • McKeesport, Pennsylvania + 1 more

Conditions: Tobacco Dependence
Interventions: Brief Intervention, Extended Treatment, Usual Care; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 956 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 3
States / cities: Berkeley, California • San Francisco, California • Stanford, California

Conditions: Psychosis, Schizophrenia
Interventions: Acceptance and Commitment Therapy (ACT), Enhanced Treatment as Usual (eTAU); Behavioral
Lead sponsor: Butler Hospital; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Healthy, Mental Disorder, Obsessive Compulsive Disorder, Schizophrenia, Tourette Syndrome
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: Not listed
Enrollment: 112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Psychiatric Disorders, Anxiety Disorders
Interventions: Gaze-Contingent Music Reward Therapy; Behavioral
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 8 Years to 17 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mental Disorder
Interventions: Enhancing Your Immune Health; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Psychotic Disorder
Interventions: Mobile After-Care Support (MACS) app, Mobile app attention control; Behavioral
Lead sponsor: Butler Hospital; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Mental Illness, Behavior Disorders, Severe Mental Illness, Psychiatric Diagnosis, Psychiatric Diseases, Psychiatric Disorders, Psychiatric Illness
Interventions: Up To Me Intervention + No Booster, Up To Me Intervention + Booster; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years and older
Enrollment: 201 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Attention Deficit Hyperactivity Disorder, Schizophrenia, Attention Deficit Disorder With Hyperactivity
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 3 Years to 120 Years
Enrollment: 4,276 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1990
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Moderately Ill Medical Inpatients at the Cornell Campus of the New York-Presbyterian Hospital
Interventions: Early assessment and referral to ancillary care services vs. standard care; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 444 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 1999
U.S. locations: 1
States / cities: New York, New York

Conditions: Seasonal Affective Disorder
Interventions: Ramelteon, Placebo; Drug
Lead sponsor: Lehigh Valley Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Allentown, Pennsylvania

Conditions: Depression
Interventions: Nurse-led case management, Treatment as usual; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 80 Years
Enrollment: 214 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 15 Years to 70 Years
Enrollment: 1,189 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Dallas, Texas

Search by objective public record fields.

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

Using Pharmacogenetics to Identify Patients With Polypharmacy at Risk of Medication Adverse Effects

Modulation of Emotion Perception in Humans Via Amygdala Stimulation

Development of a Video-based Intervention for Suicide Prevention

Bright Light Therapy as Augmentation of Depressive Symptoms on Acute Psychiatric Floor

Evaluating the Impact of Social Music

Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects

Improving Delivery of Mental Health Services for Patients With Drug Use and Other Behavioral and Emotional Problems

Genetics and Psychopathology in the 22q11 Deletion Syndrome

Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients

Substance Use Prevention in Teen Psychiatric Patients

Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders

Evaluation of Tobacco Treatment Strategies for Inpatient Psychiatry

Researching the Effectiveness of Acceptance-Based Coping During Hospitalization

I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers

Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety

Enhancing Immune Health Randomized Controlled Trial

Mobile After-Care Support App: Pilot RCT

Up To Me: Erasing the Stigma of Mental Illness on College Campuses

Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers

Hospital Outcomes: Intervention in Moderately III Patients

Ramelteon in the Treatment of Sleep and Mood in Patients With Seasonal Affective Disorder

Nurse-led Case Management for Diabetes and Cardiovascular Disease Patients With Depression

Neurophysiological Studies in Schizophrenia and Psychiatric Disorders